Tesamorelin 10mg
Lot #: N9TESA10/0428
Tesamorelin 10mg | Research Peptide
Tesamorelin is a stabilised synthetic analogue of the endogenous Growth Hormone-Releasing Hormone (GHRH), modified with an N-terminal trans-3-hexenoyl moiety. This compound is specifically engineered for the analytical investigation of somatotropic signalling cascades and the regulation of growth hormone synthesis within pituitary models. It serves as a high-affinity ligand for the GHRH receptor (GHRHR), facilitating the observation of lipolytic pathways, IGF-1 modulation, and metabolic protein synthesis in controlled research environments.
Developed for advanced laboratory applications, it delivers the uncompromising precision and consistency required for rigorous proteomic research and scientific exploration. Every batch is subject to impartial, high-resolution auditing to ensure it meets the strict purity benchmarks demanded by modern scientific standards.
Technical Specifications
- Product: Tesamorelin 10mg
- SKU: TESA10
- Purity Level: ≥99% (Assessed via HPLC)
- Physical State: Lyophilised Solid
- Molecular Formula: C221H366N72O67S
- Sequence: trans-3-Hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
Strictly for in vitro laboratory research purposes. This product is not a medicinal compound and is not intended for human or veterinary administration, clinical trials, or any form of therapeutic application. The purchaser assumes full liability for ensuring all handling and usage comply with UK regulatory standards and research chemical legislation.
Visual configuration of the primary packaging - specifically the vial closure and tamper-evident seal - may vary between production lots; technical specifications remain constant.
